- Home
- SPH vs OPK Comparison
SPH vs OPK Comparison
Compare SPH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- OPK
- Stock Information
- Founded
- SPH 1945
- OPK 2007
- Country
- SPH United States
- OPK United States
- Employees
- SPH N/A
- OPK N/A
- Industry
- SPH Other Specialty Stores
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- SPH Consumer Discretionary
- OPK Health Care
- Exchange
- SPH Nasdaq
- OPK Nasdaq
- Market Cap
- SPH 1.1B
- OPK 989.0M
- IPO Year
- SPH 1996
- OPK 1995
- Fundamental
- Price
- SPH $19.23
- OPK $1.49
- Analyst Decision
- SPH Hold
- OPK Strong Buy
- Analyst Count
- SPH 3
- OPK 3
- Target Price
- SPH $19.67
- OPK $2.75
- AVG Volume (30 Days)
- SPH 170.1K
- OPK 2.6M
- Earning Date
- SPH 02-06-2025
- OPK 02-25-2025
- Dividend Yield
- SPH 6.76%
- OPK N/A
- EPS Growth
- SPH N/A
- OPK N/A
- EPS
- SPH 1.14
- OPK N/A
- Revenue
- SPH $1,327,172,000.00
- OPK $711,408,000.00
- Revenue This Year
- SPH N/A
- OPK N/A
- Revenue Next Year
- SPH N/A
- OPK $0.00
- P/E Ratio
- SPH $16.86
- OPK N/A
- Revenue Growth
- SPH N/A
- OPK N/A
- 52 Week Low
- SPH $15.20
- OPK $0.86
- 52 Week High
- SPH $21.55
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- SPH 62.40
- OPK 45.60
- Support Level
- SPH $19.09
- OPK $1.45
- Resistance Level
- SPH $20.20
- OPK $1.51
- Average True Range (ATR)
- SPH 0.55
- OPK 0.06
- MACD
- SPH 0.22
- OPK 0.00
- Stochastic Oscillator
- SPH 78.95
- OPK 37.50
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.